Interstitial Lung Disease in a Patient Treated with Denosumab

Ruiz, Ana and Carrascosa, Miguel F and Concha, Sergio and Gil, Anibal and Rivero, Juan (2019) Interstitial Lung Disease in a Patient Treated with Denosumab. European Journal of Case Reports in Internal Medicine, 6 (7). ISSN 2284-2594

[img]
Preview
Text
document (2).pdf - Published Version

Download (473kB) | Preview
Official URL: https://www.ejcrim.com/index.php/EJCRIM/article/vi...

Abstract

Denosumab is an antiresorptive agent widely used for treating osteoporosis. Atypical femur fractures, osteonecrosis of the jaw and hypocalcaemia are well-known possible adverse effects of this drug. We present, to our knowledge, the first case report in the English literature of clinically significant interstitial lung disease likely related to denosumab.

Item Type: Article
Uncontrolled Keywords: Interstitial lung disease, denosumab, osteoporosis
Subjects: 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale)
Depositing User: Chiara D'Arpa
Date Deposited: 18 Nov 2020 20:34
Last Modified: 18 Nov 2020 20:34
URI: http://eprints.bice.rm.cnr.it/id/eprint/19487

Actions (login required)

View Item View Item